Benzinga's Top Downgrades

Analysts at Jefferies downgraded Lorillard LO from “buy” to “hold.” The price target for Lorillard has been lowered from $54 to $51. Lorillard's shares closed at $47.47 yesterday. Analysts at JP Morgan downgraded Itron ITRI from “neutral” to “underweight.” The price target for Itron has been lowered from $41 to $30. Itron's shares closed at $39.19 yesterday. Roth Capital downgraded Depomed DEPO from “buy” to “neutral.” The target price for Depomed has been raised from $12 to $12.50. Depomed's shares closed at $12.46 yesterday. Analysts at Credit Suisse downgraded The Medicines Company MDCO from “outperform” to “neutral.” The target price for Medicines Company has been lowered from $45 to $35. Medicines Company's shares closed at $33.10 yesterday.